|
|
|
|
|
PEER-TO-PEER CLINICAL CONVERSATIONS |
|
|
|
|
|
|
Prostate Cancer Disparities: Addressing Inequities and Empowering Change
|
Kelvin Moses, MD, Ph.D.
Zach Klaassen and Kelvin Moses discuss prostate cancer disparities in 2023. Dr. Moses highlights the disparities black men face in prostate cancer, including lower screening rates, higher grades or stages of disease, and a higher risk of death compared to white men. |
|
|
|
|
|
|
|
|
|
|
| Promoting Diversity and Empowering Black Urologists: The R. Frank Jones Urological Society |
Linda McIntire, MD
In this conversation, Sam Washington interviews Linda McIntire, a urologist at My Michigan Health and the President of the R Frank Jones Urological Society. |
|
|
|
|
|
|
|
|
|
|
| Breaking Barriers in Urologic Research: Tackling Health Disparities and Collaborative Solutions |
Cheryl Lee, MD
Sam Washington and Cheryl Lee discuss the Challenges of Urologic Research Symposium, focusing on overcoming health disparities in urologic research.
|
|
|
|
|
|
|
|
|
|
|
| Racial Disparities in Future Development of Lethal Prostate Cancer Based on PSA Levels in Midlife |
| Matthew Davis |
| Matthew Davis discusses a study evaluating racial disparities in the future development of lethal prostate cancer based on PSA level measurements in midlife. The objective of this study was to examine racial disparities in prostate cancer mortality based on initial midlife PSA results in a North American population. |
|
|
|
|
|
| Disparities in Delayed Diagnosis, Access to Treatment, and Treatment Delays Among Hispanic Men With Metastatic Prostate Cancer |
| Nishwant Swami, MPH |
| Nishwant Swami discusses disparities in diagnosis, access to treatment, and treatment delays for Hispanic men with metastatic prostate cancer. The data demonstrates notable disparities in prostate cancer diagnosis and treatment for Hispanic men, with meaningful differences when stratified by racial subgroup and Hispanic country of origin. |
|
|
|
|
|
|
|
|
|
|
| Racial Disparities in Rates of Gleason Grade Reclassification in a Multi-Institutional Prostate Cancer Active Surveillance Cohort: A Pennsylvania Urology Regional Collaborative (PURC) Analysis |
| Rohit Reddy, MD, BA |
| Rohit Reddy discusses racial disparities in Gleason grade reclassification among patients undergoing active surveillance in the Pennsylvania Urology Regional Collaborative (PURC). The authors conclude that currently utilized selection criteria and surveillance protocols fail to account for potential racial differences in oncologic outcomes. Thus, AA men may need alternate AS surveillance approaches potentially including adjunct studies for accurate risk stratification and monitoring. |
|
|
|
|
|
| Predictors of Overall Survival Among Black South African Men Treated with Androgen-Deprivation Therapy for Metastatic Prostate Cancer. |
| Yoanna Pumpalova, MD |
| Men of African ancestry experience higher incidence, including de novo metastatic disease, and death from prostate cancer. This is despite the fact that in certain controlled settings, African ancestry prostate cancers are more responsive to therapy when appropriately deployed. The authors of this poster sought to determine, using clinicopathological data, associative predictors of overall survival for South African men treated with androgen deprivation therapy. |
|
|
|
|
|
| Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men |
| Spyridon Basourakos, MD
|
| Spyridon Basourakos presents on the harm-to-benefit ration of prostate cancer screening in Black men over the past three decades. Prostate cancer screening, using serum prostate-specific antigen testing, has profoundly impacted the epidemiology of prostate cancer in the US, increasing the incidence and decreasing mortality. However, PSA-based prostate cancer screening is controversial given risks of overdiagnosis and overtreatment.
|
|
|
|
|
|
| Racial Variation in MRI-Guided Prostate Biopsy Significant Cancer Detection Among Black and White Men
|
| Callan Brownfield, MD |
| Callan Brownfield discusses racial variation in MRI-guided prostate biopsy significant cancer detection among Black and White men. Prostate biopsies guided by MRI have superior cancer detection rates compared to traditional ultrasound-only guided biopsies. The objective of this study was to evaluate comparative cancer detection of MRI-guided prostate biopsies based on self-reported patient race. |
|
|
|
|
|
|
